SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-024983
Filing Date
2022-11-14
Accepted
2022-11-14 16:05:45
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K aclx-20221114.htm   iXBRL 8-K 60994
2 EX-99.1 aclx-ex99_1.htm EX-99.1 152021
3 GRAPHIC img167846775_0.jpg GRAPHIC 11022
  Complete submission text file 0000950170-22-024983.txt   360876

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aclx-20221114_pre.xml EX-101.PRE 10667
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aclx-20221114.xsd EX-101.SCH 2454
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aclx-20221114_lab.xml EX-101.LAB 14572
8 EXTRACTED XBRL INSTANCE DOCUMENT aclx-20221114_htm.xml XML 5112
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 221385079
SIC: 2836 Biological Products, (No Diagnostic Substances)